RecruitingPhase 4NCT06743802

The Effect of Coenzyme Q10 in Preventing Pain After Thoracoscopic Surgery

The Effect of Coenzyme Q10 in Preventing Pain After Thoracoscopic Surgery: a Randomized Controlled Trial


Sponsor

The Second Affiliated Hospital of Chongqing Medical University

Enrollment

264 participants

Start Date

Jan 9, 2025

Study Type

INTERVENTIONAL

Conditions

Summary

This study aimed to assess the effectiveness of Coenzyme Q10 in preventing both acute and chronic pain following thoracoscopic surgery, with a focus on its potential benefits in reducing the incidence and severity of pain.


Eligibility

Min Age: 18 YearsMax Age: 75 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a drug called Coenzyme Q10 and Placebo for people with postoperative pain. The study is currently recruiting participants at 1 location. People eligible for this study include aged 18 Years to 75 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DRUGCoenzyme Q10

Coenzyme Q10 was administered from admission to one month after discharge at a dose of 200 mg per day (200 mg/qd).

OTHERPlacebo

The placebo was administered from hospital admission until one month after discharge.


Locations(1)

Guangyou Duan

Chongqing, Chongqing Municipality, China

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06743802


Related Trials